Target intelligence / Profile preview

Salivary gland tissue (N/A)

Target
N/A
Molecular classification
Other
01

Overview

Salivary gland tissue consists of the parotid, submandibular, and sublingual glands, along with numerous minor glands distributed throughout the oral mucosa. Its primary biological function is the production and secretion of saliva, which is essential for lubricating the oral cavity, initiating the digestion of starches via alpha-amylase, and protecting dental enamel through buffering and antimicrobial proteins (StatPearls, 2023). In clinical medicine, salivary gland tissue is a major site of pathology in autoimmune diseases like Sjögren's syndrome, where lymphocytic infiltration leads to glandular destruction and chronic xerostomia (NIH, 2022). While the tissue itself is not a single molecular target, it expresses high levels of muscarinic M3 receptors, which are the pharmacological targets for secretagogues like pilocarpine and cevimeline used to treat dry mouth (PubChem). Additionally, the tissue is susceptible to various neoplasms and is frequently damaged as an off-target effect of head and neck radiation therapy or radioiodine treatment for thyroid cancer (PubMed, 2021). Understanding the physiology and receptor profile of this tissue is crucial for managing disorders of salivation and minimizing treatment-related toxicities.

Other names
Salivary glandsGlandula salivaria
02

Mechanism of action

Pharmacological modulation of salivary gland tissue typically involves muscarinic M3 receptor agonism to stimulate secretion, inhibition of acetylcholine release to treat sialorrhea, or competitive muscarinic antagonism to reduce secretions (StatPearls, 2023; PubChem).

03

Biological functions

Saliva secretionDigestionOral homeostasisAntimicrobial defenseLubrication
04

Disease associations

Sjögren's syndromeSalivary gland neoplasmSialadenitisXerostomiaSialorrhea
05

Safety considerations

Xerostomia (dry mouth)SialadenitisRadiation-induced fibrosisSecondary malignancy risk from radioiodine
06

Interacting drugs

Pilocarpine

4 more in the full profile.

07

Biomarkers

Unstimulated whole salivary flow (UWSF)Anti-SSA/Ro antibodiesAnti-SSB/La antibodiesSalivary gland ultrasonography (SGUS) score

Beyond the preview

Go deeper on Salivary gland tissue (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salivary gland tissue (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call